In order to join forces and to leverage the value of their EHR data supporting the fight against the COVID-19 virus, an international consortium (4CE) of 96 hospitals across 5 countries (www.covidclinical.net) has been initiated by the i2b2/tranSMART foundation in the last weeks of March 2020. The MIRACUM sites Erlangen, Freiburg and Mannheim, which were already actively involved in the i2b2/tranSMART community, decided to join this consortium, acquired IRB and UAC approval for this project and provided aggregated data for a phase 1 analysis.
In this phase, first clinical and epidemiological questions about the incidence and clinical course of COVID-19 patients could be analyzed and early results have just been published as preprint, which you can find here: https://www.medrxiv.org/content/10.1101/2020.04.13.20059691v1.full.pdf
In order to join forces and to leverage the value of their EHR data supporting the fight against the COVID-19 virus, an international consortium (4CE) of 96 hospitals across 5 countries (www.covidclinical.net) has been initiated by the i2b2/tranSMART foundation in the last weeks of March 2020. The MIRACUM sites Erlangen, Freiburg and Mannheim, which were already actively involved in the i2b2/tranSMART community, decided to join this consortium, acquired IRB and UAC approval for this project and provided aggregated data for a phase 1 analysis.
In this phase, first clinical and epidemiological questions about the incidence and clinical course of COVID-19 patients could be analyzed and early results have just been published as preprint, which you can find here: https://www.medrxiv.org/content/10.1101/2020.04.13.20059691v1.full.pdf